The total return over the past 12 months is -36.67% vs. +16.94% for the S&P 500. So far it's up -52.76% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (36.67%) | (1.69%) | +2.15% | +1.39% | N/A | N/A |
| Total Return CAGR | (36.67%) | (1.69%) | +2.15% | +1.39% | N/A | N/A |
| Revenue CAGR | +14.31% | +14.60% | +19.91% | N/A | N/A | N/A |
| Net Income CAGR | +32.10% | N/A | +18.64% | N/A | N/A | N/A |
| EPS CAGR | +30.10% | N/A | +20.48% | N/A | N/A | N/A |
| Free Cash Flow CAGR | +62.67% | +11.75% | +26.38% | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +62.14% | +11.74% | +25.29% | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Collegium Pharmaceutical, Inc. (COLL)
| Year | Start price | End price | COLL Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $46.30 | $21.87 | (52.76%) | +14.51% | (67.27%) |
| 2025 | $28.65 | $46.30 | +61.61% | +17.72% | +43.89% |
| 2024 | $30.78 | $28.65 | (6.92%) | +24.89% | (31.81%) |
| 2023 | $23.20 | $30.78 | +32.67% | +26.19% | +6.48% |
| 2022 | $18.68 | $23.20 | +24.20% | (18.17%) | +42.37% |
| 2021 | $20.03 | $18.68 | (6.74%) | +28.74% | (35.48%) |
| 2020 | $20.58 | $20.03 | (2.67%) | +18.37% | (21.04%) |
| 2019 | $17.17 | $20.58 | +19.86% | +31.22% | (11.36%) |
| 2018 | $18.46 | $17.17 | (6.99%) | (4.56%) | (2.43%) |
| 2017 | $15.57 | $18.46 | +18.56% | +21.70% | (3.14%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
